U. Forward Fest to engage community on research and development for the future – The Daily Princetonian

On Oct. 23 and 24, the University will kick off its first monthly Forward Fest event, featuring high-level administrators and accomplished faculty members who work in innovation, as well as alumni hosts and moderators.

According to a press release, the online series, which will continue throughout the year, aims to spark dialogue across the global University community to engage with and explore big ideas and their infinite possibilities for shaping the future.

The Forward Fest speakers, or Forward Thinkers, are drawn from a variety of disciplines. Their presentations will discuss how their research and approaches have pivoted to analyze and address urgent contemporary issues.

The first half of the inaugural Forward Fest will take place on Friday, Oct. 23, at 8:00 p.m. EDT. President Christopher Eisgruber 83, Provost Deborah Prentice, and a number of other administrators are slated to speak on what is to come in A Year of Forward Thinking and how the University community can engage with topics such as public health and bioengineering with an orientation towards the future.

One of the featured administrators, Dean of Engineering and Applied Science Andrea Goldsmith, wrote in an email to the The Daily Princetonian that she will discuss plans to significantly grow our engineering faculty and to build a new neighborhood for the school that will foster collaboration within engineering and across all of Princeton.

I also plan to discuss our vision to launch interdisciplinary initiatives in bioengineering, quantum computing, robotics, smart cities, and data science, Goldsmith wrote. Advances in these topics will enhance health and medicine, spur new computing paradigms, improve the efficiency and robustness of our infrastructure, and mitigate climate change and energy shortages.

The second day of the event will take place on Saturday at 1:00 p.m. EDT and feature three panels of faculty members on the subjects of public health, social justice, and the U.S. election, respectively.

History professor Kevin Kruse, who will participate in the election panel, said the discussions aim to serve community members in an email to the Prince.

Forward Fest was designed to focus attention on the in service part of the Universitys mission, and the webinar on the 2020 election is designed to be a service to students, faculty, alumni and others who have questions and concerns about this pivotal moment, Kruse wrote.

Kruse added that hell be providing context about a few key issues people have been talking about these past few months voting rights and voter suppression, possible reforms to the Electoral College, Congress, and the Supreme Court, and generally how this election compares to past ones.

Professor of computer science Andrew Appel 81, another faculty member on the election panel, plans to focus on the technology of how we vote, and how its inaccuracy, insecurity, and outright hackability can alter the outcome of elections, he wrote in an email to the Prince.

[M]ost (but not all) jurisdictions vote on technology that is accurate and is securable though not for the reasons you might think and now we should pay attention to the audits and procedures that would make our voting systems truly secure and trustworthy, Appel added.

Forward Fest is part of A Year of Forward Thinking, the Universitys recently-announced community engagement campaign.

Forward Fest events are free and open to the public. All programming will be livestreamed on the Forward Fest website and the Universitys YouTube channel.

Read this article:
U. Forward Fest to engage community on research and development for the future - The Daily Princetonian

Technical Ceramics Market Competitive Benchmarking And Regions Analysis – Cole of Duty

The Global Technical Ceramics Market Analysis to 2027 is a specialized and in-depth study of the chemicals and materials industry with a special focus on the global market trend analysis. The report aims to provide an overview of technical ceramics market with detailed market segmentation by material, product type, application, end-use industry and geography. The global technical ceramics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading technical ceramics market players and offers key trends and opportunities in the market.

Request a Sample Copy of the Research Report:https://www.theinsightpartners.com/sample/TIPRE00003946/

Note The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries. This report on Technical Ceramics Market provides the analysis on impact on Covid-19 on various business segments and country markets. The reports also showcase market trends and forecast to 2027, factoring the impact of Covid -19 Situation.

Technical ceramics are high-performance ceramics designed for technical applications rather than decorative. They are mainly characterized by properties such as mechanical and dimensional stability and heat resistance. Technical ceramics are therefore suitable for highly stressed components in machines and devices. Technical ceramics find use in medical and bioengineering and semiconductors as well.

Avail discount on this report @https://www.theinsightpartners.com/discount/TIPRE00003946/

Major vendors covered in this report:

The study conducts SWOT analysis to evaluate strengths and weaknesses of the key players in the Technical Ceramics market. Further, the report conducts an intricate examination of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The report also predicts the influence of different industry aspects on the Technical Ceramics market segments and regions.

Interested in purchasing this Report? Click here @https://www.theinsightpartners.com/buy/TIPRE00003946/

The global technical ceramics market is segmented on the basis of material, product type, application and end-use industry. By material, the market is segmented as alumina ceramics, titanate ceramics, zirconate ceramics, ferrite ceramics and others. Based on product type, the market is segmented as monolithic ceramics, ceramic matrix composites and ceramic coatings. On the basis of the application the market is segmented as electrical equipment, catalyst supports, electronic devices, wear parts, engine parts, filters, bio ceramics and others. The market on the basis of the end-use industry is classified as electrical & electronics, automotive, industrial, medical and others.

Our reports will help clients solve the following issues:

Insecurity about the future:

Our research and insights help our clients anticipate upcoming revenue compartments and growth ranges. This will help our clients invest or divest their assets.

Understanding market opinions:

It is extremely vital to have an impartial understanding of market opinions for a strategy. Our insights provide a keen view on the market sentiment. We keep this reconnaissance by engaging with Key Opinion Leaders of a value chain of each industry we track.

Understanding the most reliable investment centers:

Our research ranks investment centers of market by considering their future demands, returns, and profit margins. Our clients can focus on most prominent investment centers by procuring our market research.

Evaluating potential business partners:

Our research and insights help our clients identify compatible business partners.

Contact Us:

Call: +1-646-491-9876

Email:[emailprotected]

Here is the original post:
Technical Ceramics Market Competitive Benchmarking And Regions Analysis - Cole of Duty

$2.3 Million Grant Will Support Development of Virtual Operating Room Team Training – Mirage News

Shared virtual system will provide new opportunities for clinical team training

TROY, N.Y. A surgeon makes an incision on a virtual patient with support from a perioperative nurse, while an anesthesiologist monitors the patients vital signs. As the procedure continues, the team members navigate together through any challenges that arise even though each of them may be participating from different rooms, buildings, or even cities.

A new $2.3 million grant from the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health will support a research effort led by Rensselaer Polytechnic Institute to make that virtual scenario and others like it a reality.

People will be wearing head-mounted displays, and they will be immersed in a virtual operating room working on a virtual patient as a team, said Suvranu De, the director of the Center for Modeling, Simulation, and Imaging in Medicine at Rensselaer, who is heading up this effort. We want to have an expert team in the operating room focused on the treatment of a patient, and not just a team of experts.

De and his team have dedicated more than a decade of research to making surgery safer by developing virtual reality-based surgical simulations that closely mimic the optics and haptics a surgeon may encounter in the operating room.

Those simulations have allowed surgeons to practice essential technical skills especially those associated with hand-eye coordination in a no-risk environment. Now, the Rensselaer researchers are developing a collaborative virtual reality-based surgical simulation environment that allows medical professionals to practice technical, cognitive, and interpersonal skills as a team.

Conceptually, this approach is similar to crew resource management practiced by aviation pilots, which has led to a significant reduction in aircraft accidents. The Virtual Operating Room Team Experience (VORTeX) simulation system will provide realistic distractions, interruptions, and other stressors that medical professionals may encounter in an operating room.

Traditionally, this type of simulation training has required mannequins, instructors, and a dedicated space, as well as significant coordination and resources. In contrast, the VORTeX system will be both distributed and asynchronous allowing participants to join the simulation from different locations, and instructors to review the simulation and provide feedback at their convenience. Machine learning algorithms will be used to crunch the data and provide feedback to participants, who can return to the virtual environment to review their performance.

The COVID-19 pandemic has highlighted the importance of such a flexible approach. Educators and professionals are looking for new ways to train and complete procedures while maintaining social distance.

Teams have to train in a very different way because of COVID-19, De said. These are very complicated processes, which actually expose the clinicians to threats, and there is no second chance. So being able to perform these kinds of things in the virtual environment does open up significant possibilities.

De is working with Alhussein Abouzeid, a professor of electrical, computer, and systems engineering at Rensselaer, as well as teams from Beth Israel Deaconess Medical Center, Albany Medical Center, and the University of Central Arkansas to develop the VORTeX. A steering committee of the American College of Surgeons (ACS) will advise the team. The technology developed will have the potential to positively impact training programs offered through the national network of ACS-accredited simulation centers.

We hope this spreads through the country and the world and that it has the same effect this kind of training has had on the aerospace industry in enhancing patient safety, De said.

Follow this link:
$2.3 Million Grant Will Support Development of Virtual Operating Room Team Training - Mirage News

Glyscend Therapeutics raises $20.5M Series A to advance a new way of treating Type 2 diabetes – Technical.ly

Baltimore-based biopharmaceutical company Glyscend Therapeutics closed a $20.5 million financing round that will help to advance its treatment for Type 2 diabetes toward clinical trials next year.

The round was led by healthcare-focused investors Brandon Capital Partners and Sant Ventures. In 2019, the company also previously received seed funding from Breakout Labs, which is a fund in the Thiel Foundation of Paypal cofounder and investor Peter Thiel.

Glyscend will use the funding for product development, scaling up manufacturing, and proof-of-concept clinical trials that are slated to begin in Australia in 2021.

The company is developing an oral therapy that is designed to offer specific benefits of surgery, without the need for invasive procedures.

The technology we are developing was inspired by the remarkable efficacy of gastric bypass surgery in correcting the metabolic disorder associated with type 2 diabetes, said Dr. Ashish Nimgaonkar, CEO of Glyscend, in a statement. Our goal is to develop an oral medication that works locally in the gastrointestinal tract to provide the benefits of gastric bypass surgery while greatly reducing the potential risks and complications.

Founded in 2104, the company evolved from research that originated at the Johns Hopkins Center for Bioengineering Innovation and Design, which has served as a launch point for multiple startups, via collaboration between the labs of Nimgaonkar and Dr. Jay Pasricha. In this research, scientists were evaluating the mechanisms that result in significantly improved glucose and metabolic regulation following certain types of weight loss surgery, Nimgaonkar said. In seeking to create non-absorbable drugs, the team tapped the expertise of medicinal polymer chemist Dr. Thomas Jozefiak, who is chief scientific officer.

It licensed technology from the university, and is now based at the FastForward 1812 innovation hub near Johns Hopkins Hospital in East Baltimore, which has become a biotech hub through offering access to coveted wet lab space in the city and proximity to other young companies.

Being located close to John Hopkins University has been vital for us grow by tapping into the deep scientific expertise roots, Nimgaonkar said. It also offers access to the wealth of knowledge from one of the countrys leading healthcare universities.

Additional materials science research and development is also conducted at a Lowell, Massachusetts, location of JLABS, which is Johnson & Johnsonsstartup incubator.

Along with the funding, entrepreneur and executive Dr. Karen Talmadge, who cofounded Medtronic-acquired medical device company Kyphonand is a 25-year member of the American Diabetes Association, joined the companys board.

Type 2 diabetes is a terrible disease whose personal and societal impact is both under-appreciated and deeply misunderstood, Talmadge said in a statement. I am honored to join Glyscends board to help fulfill the companys mission of providing life-changing benefits to patients with diabetes by reducing or eliminating the burden of disease.

Follow this link:
Glyscend Therapeutics raises $20.5M Series A to advance a new way of treating Type 2 diabetes - Technical.ly

3,000 people wanted for new NI study which will show if you have had Covid-19 – Belfast Newsletter

Ulster University is carrying out the study

Led by Professors Tara Moore and Jim McLaughlin, the novel PANDEMIC (Protective/risk factors, ANtibody response, Dna, gEnoMICs) study will also investigate the genetic risk factors for Covid-19 symptoms.

Using Ulster Universitys Covid-19 app and the UK Government Rapid Test Consortiums highly sensitive lateral flow test, the project team hopes to recruit 3,000 participants to get a better understanding of the number of people in NI who have been exposed to the virus and whether different age groups or ethnicities make antibodies.

Participants who are antibody positive will be assessed over time for up to one year to see how long their antibodies are present.

Professor Jim McLaughlin, Director of the Nanotechnology and Integrated Bioengineering Centre at Ulster University commented: This important study will give us a good indication of the number of people exposed to Covid-19 in Northern Ireland and the immune response in the general population.

Sign up to our public interest bulletins - get the latest news on the Coronavirus

Sign up to our public interest bulletins - get the latest news on the Coronavirus

All tests will be conducted using the UK Government Rapid Test Consortiums new highly sensitive antibody test. Our study will help to validate the test and test user experience before the government deploys these home tests to inform their recovery plans and better handle future outbreaks or even monitor the success of a vaccine when it is eventually developed.

Professor Tara Moore, Professor of Personalised Medicine at Ulster University said: Everyone is eager to know if they have had Covid-19. Many people with symptoms were advised to stay at home and self-isolate without being tested so we just dont know how many people in Northern Ireland have been affected.

This novel study is a great opportunity to find out if you have Covid-19 antibodies and help us learn more about COVID-19 exposure and immunity in Northern Ireland.

Its a very simple pin prick test and participants receive their results within 15 minutes. Those who test positive will be invited for a blood test. These blood samples will allow us to store DNA and perform genetic analysis to look for factors that influence how severe a COVID-19 infection could be as and when these genetic factors are discovered.

The Ulster University PANDEMIC study is partly funded by Kingsbridge Private Hospital.

How to take part: Researchers from the Schools of Biomedical Science and Engineering are looking for volunteers between the ages of 18 and 90, whether they think they have had Covid-19 or not, to survey the presence of antibodies to the SARS-CoV-2 coronavirus in the blood of the people of Northern Ireland.

Eligible participants will be asked to

- Download the Ulster University COVID-19 smartphone app

- Answer questions on their age, health and any COVID-19 symptoms they have, or have had

- Attend a one-off short drive-through appointment in the University to take a finger-prick blood test

- If participants test positive for the COVID-19 antibody they will be invited to give a blood sample

- If you are interested in participating in the study please email pandemicstudy@ulster.ac.uk

Go here to read the rest:
3,000 people wanted for new NI study which will show if you have had Covid-19 - Belfast Newsletter

LSU Democracy at Work advocates to rename 11 other buildings in addition to Middleton Library – The Reveille, LSU’s student newspaper

The recent name change of Middleton Library, which was approved by the Board of Supervisors Friday, has led many students to advocate for the renaming of 11 other buildings on campus named after Confederate officers, segregationists and Louisiana governors with a history of exclusionary policies.

The students at Democracy at Work LSU created a petition to rename the other 11 buildings. Bioengineering and math senior Soheil Saneei said that Exquisite Williams petition is what inspired the fight for change.

The petition currently has over 3,000 signatures. Their goal is not only to get the names changed with petition, but also to start a larger conversation, according to philosophy, political science and sociology senior Sebastian Brumfield Mejia.

We are trying to start an initiative to actually systemically change things as well, [and] to really generate a conversation about that we really have to generate a conversation about these buildings, Brumfield Mejia said.

Brumfield Mejia hopes that renaming the buildings will be a catalyst for further activism.

We hope that by making these twelve symbolic changes we can begin to broaden the conversation about anti-racist structural changes on campus beyond just Middleton, Brumfield Mejia said. And then hopefully transition the conversation from symbolic changes to actual material changes that will affect black students and faculty workers on campus.

Democracy at Work LSU put together research to present to the Board of Supervisors as well as a list of new building name suggestions. Many of the suggestions include prestigious black University graduates, such as the first black woman to graduate from LSU, Pearl Henry Payne, and the first black LSU Law School graduate, Ernest N. Dutch Morial.

The group also emphasized LSUs policy to name a building. University policy states the person must have significant ties to the University or be of outstanding character. Several of the 11 buildings are named after individuals with no known connection to the University, such as Jackson Hall, named after President Andrew Jackson, and Beauregard Hall, named after Confederate General PGT Beauregard.

Brumfield Mejia said that if the Board of Supervisors demonstrates it is not ready to make the changes, the group will ask for students to be ready to organize protests in the fall semester.

Democracy at Work LSU is committed to promote change and help students reflect on what is happening in their daily lives that needs to be improved.

We want to talk about the structures that exist, Saneei said. How do they manifest in our daily lives? Thats what we need to focus on.

More here:
LSU Democracy at Work advocates to rename 11 other buildings in addition to Middleton Library - The Reveille, LSU's student newspaper

Scientists Work Towards a CRISPR-based COVID-19 Therapy – Technology Networks

A team of scientists from Stanford University is working with researchers at theMolecular Foundry, a nanoscience user facility located at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19.

Last year, Stanley Qi, an assistant professor in the departments of bioengineering, and chemical and systems biology at Stanford University and his team had begun working on a technique called PAC-MAN - or Prophylactic Antiviral CRISPR in human cells - that uses the gene-editing tool CRISPR to fight influenza.

But that all changed in January, when news of the COVID-19 pandemic emerged. Qi and his team were suddenly confronted with a mysterious new virus for which no one had a clear solution. "So we thought, 'Why don't we try using our PAC-MAN technology to fight it?'" said Qi.

Since late March, Qi and his team have been collaborating with a group led byMichael Connolly, a principal scientific engineering associate in the Biological Nanostructures Facility at Berkeley Lab's Molecular Foundry, to develop a system that delivers PAC-MAN into the cells of a patient.

Like all CRISPR systems, PAC-MAN is composed of an enzyme - in this case, the virus-killing enzyme Cas13 - and a strand of guide RNA, which commands Cas13 to destroy specific nucleotide sequences in the coronavirus's genome. By scrambling the virus's genetic code, PAC-MAN could neutralize the coronavirus and stop it from replicating inside cells.

It's all in the delivery

Qi said that the key challenge to translating PAC-MAN from a molecular tool into an anti-COVID-19 therapy is finding an effective way to deliver it into lung cells. When SARS-CoV-2, the coronavirus that causes COVID-19, invades the lungs, the air sacs in an infected person can become inflamed and fill with fluid, hijacking a patient's ability to breathe.

"But my lab doesn't work on delivery methods," he said. So on March 14, they published a preprint of their paper, and even tweeted, in the hopes of catching the eye of a potential collaborator with expertise in cellular delivery techniques.

Soon after, they learned of Connolly's work on synthetic molecules called lipitoids at the Molecular Foundry.

Lipitoids are a type of synthetic peptide mimic known as a "peptoid" first discovered 20 years ago by Connolly's mentor Ron Zuckermann. In the decades since, Connolly and Zuckermann have worked to develop peptoid delivery molecules such as lipitoids. And in collaboration with Molecular Foundry users, they have demonstrated lipitoids' effectiveness in the delivery ofDNAandRNAto a wide variety of cell lines.

Today, researchers studying lipitoids for potentialtherapeutic applicationshave shown that these materials are nontoxic to the body and can deliver nucleotides by encapsulating them in tiny nanoparticles just one billionth of a meter wide - the size of a virus.

Now Qi hopes to add his CRISPR-based COVID-19 therapy to the Molecular Foundry's growing body of lipitoid delivery systems.

In late April, the Stanford researchers tested a type of lipitoid - Lipitoid 1 - that self-assembles with DNA and RNA into PAC-MAN carriers in a sample of human epithelial lung cells.

According to Qi, the lipitoids performed very well. When packaged with coronavirus-targeting PAC-MAN, the system reduced the amount of synthetic SARS-CoV-2 in solution by more than 90%. "Berkeley Lab's Molecular Foundry has provided us with a molecular treasure that transformed our research," he said.

The team next plans to test the PAC-MAN/lipitoid system in an animal model against a live SARS-CoV-2 virus. They will be joined by collaborators at New York University and Karolinska Institute in Stockholm, Sweden.

If successful, they hope to continue working with Connolly and his team to further develop PAC-MAN/lipitoid therapies for SARS-CoV-2 and other coronaviruses, and to explore scaling up their experiments for preclinical tests.

"An effective lipitoid delivery, coupled with CRISPR targeting, could enable a very powerful strategy for fighting viral disease not only against COVID-19 but possibly against newly viral strains with pandemic potential," said Connolly.

"Everyone has been working around the clock trying to come up with new solutions," added Qi, whose preprint paper was recently peer-reviewed and published in the journalCell. "It's very rewarding to combine expertise and test new ideas across institutions in these difficult times."

Reference: Abbott et al. (2020). Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza. Cell. DOI: https://doi.org/10.1016/j.cell.2020.04.020.

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read more:
Scientists Work Towards a CRISPR-based COVID-19 Therapy - Technology Networks

Synthetic Plant Hormones Market Research and New Developments 2020 to 2026 – Cole of Duty

Global Synthetic Plant Hormones Market Size, Status and Forecast 2020-2026

The Synthetic Plant Hormones Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive data that enhances the understanding, scope, and application of this report.

Get Free Sample Copy of this Report:

https://www.marketinsightsreports.com/reports/06122087119/global-synthetic-plant-hormones-market-insights-forecast-to-2026/inquiry?source=coleofduty&Mode=07

Top Leading Companies of Global Synthetic Plant Hormones Market are Zhejiang Qianjiang Biochemical, Shanghai Tongrui Biotech, Jiangxi Xinruifeng Biochemical, Sichuan Longmang Fusheng Biotech, Jiangsu Fengyuan Bioengineering, Jiangsu Bailing Agrochemical and others.

Global Synthetic Plant Hormones Market Split by Product Type and Applications:

This report segments the global Synthetic Plant Hormones market based onTypesare:Concentration of 90%

Concentration of 85%

Others

Based onApplication, the Global Synthetic Plant Hormones market is segmented into:Cereals & Grains

Fruits

Vegetables

Others

Synthetic Plant Hormones Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis, and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments, and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary, and advanced information about the Synthetic Plant Hormones Market global status and trend, market size, share, growth, trends analysis, segment, and forecasts from 2020-2026.

Explore Full Report With Detailed TOC Here:

https://www.marketinsightsreports.com/reports/06122087119/global-synthetic-plant-hormones-market-insights-forecast-to-2026?source=coleofduty&Mode=07

Highlights of the Synthetic Plant Hormones Market Report:

Detailed overview of Synthetic Plant Hormones Market Changing the Synthetic Plant Hormones market dynamics of the industry In-depth market segmentation by Type, Application, etc. Historical, current and projected Synthetic Plant Hormones market size in terms of volume and value Recent industry trends and developments Competitive landscape of Synthetic Plant Hormones Market Strategies of key players and product offerings Potential and niche segments/regions exhibiting promising growth.

The research includes historic data from 2015 to 2020 and forecasts until 2026 which makes the report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Finally, the Synthetic Plant Hormones Market report is the believable source for gaining the market research that will exponentially accelerate your business. The report gives the principle locale, economic situations with the item value, benefit, limit, generation, supply, request, and market development rate and figure, and so on. Synthetic Plant Hormones industry report additionally Presents a new task SWOT examination, speculation attainability investigation, and venture return investigation.

We Offer Customization On Report Based On Specific Client Requirement: Free country Level analysis for any 5 countries of your choice. Free Competitive analysis of any 5 key market players. Free 40 analyst hours to cover any other data point.

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information, and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact Us:

Irfan Tamboli (Head of Sales) Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687

[emailprotected] | [emailprotected]

Follow this link:
Synthetic Plant Hormones Market Research and New Developments 2020 to 2026 - Cole of Duty

SwRI Awarded $1.9M Contract to Develop Treatment for COVID-19 in Collaboration with DOD – HPCwire

May 28, 2020 Using Department of Defense supercomputers, Southwest Research Institute is virtually screening millions of drug compounds to search for and test possible treatment options for the novel coronavirus 2019. The Henry M. Jackson Foundation for the Advancement of Military Medicine has awarded SwRI a $1.9 million, one-year contract to support efforts to develop a COVID-19 treatment.

SwRI is working with the DOD High Performance Computing Modernization Program to rapidly screen potential drug compounds using SwRIs 3D drug screening software tool, Rhodium. Using supercomputers speeds up the screening process allowing evaluation of possible therapeutic compounds to increase from 250,000 compounds a day to more than 40 million compounds in just one week.

This grant will enable SwRI to collaborate to develop safe antiviral drug therapy treatment options for COVID in record time, said Dr. Joe McDonough, director of SwRIs Pharmaceutical and Bioengineering Department. SwRI is using its Rhodium modeling technology to continue the search for an effective drug and has already screened more than 40 million compounds.

As a drug development tool, Rhodium helps scientists rapidly predict how protein structures in infectious diseases will bind with drug compounds to find viable candidates for development into therapies.

Rhodium is helping us quickly identify highly probable compounds from databases with existing drug candidates to narrow down our focus, said Dr. Jonathan Bohmann, an SwRI principal scientist leading COVID-19 drug screening work. As we identify potential candidates, we have moved them on to testing.

SwRI is also conducting laboratory screening of compounds, assessing toxicity to help filter potential treatment options. Once compounds are tested and meet the criteria set for safety and efficacy, SwRI will be involved in formulation development and production scale-up for the compounds. The Institute has previously used this process to develop drug treatment therapies for Ebola virus, malaria and other infectious diseases.

This is definitely a priority project, and we understand the urgency, said Nadean Gutierrez, project manager and SwRI research scientist. We are utilizing Rhodium and other screening tools to expeditiously screen existing compounds as well as identify novel drug candidates against COVID-19. Right now, we are working toward testing up to 500 compounds in laboratory toxicity testing. Once these compounds have been identified by Rhodium and then passed toxicity testing, they move to the Texas Biomedical Research Institute (Texas Biomed) for the next steps in testing.

When news began to emerge about COVID-19, SwRI immediately began the search for a treatment, teaming with other scientists and tapping into SwRI internal research funding.

SwRI began looking for a treatment to stop COVID-19 as soon as the virus protein was published in February, McDonough said. Working with existing collaborators at Texas Biomed, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and Walter Reed Army Institute of Research (WRAIR), SwRI scientists identified 60 compounds from a library of more than 6 million compounds. These are already being tested at USAMRIID and Texas Biomed. SwRI continues to fund the development of a treatment internally along with collaborators.

This work may also help find future treatment options for severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS), which show similar binding domains as the COVID-19 protein.

Under this program, SwRI will identify drug candidates that will be tested at USAMRIID, WRAIR and TBRI with the goal of demonstrating efficacy as early as next year, McDonough said.

The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, Maryland 21702-5014 is the awarding and administering acquisition office.

This work was supported by the U.S. Army Medical Research Acquisition Activity, under Award No. W81XWH1820040. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the U.S. Army Medical Research Acquisition Activity.

For more information, visitStructure-Based Virtual ScreeningorcontactTracey M.S. Whelan,+1 210 522 2256, Communications Department, Southwest Research Institute, PO Drawer 28510, San Antonio, TX 78228-0510.

About Southwest Research Institute

We are R&D problem solvers providing independent, premier services to government and industry clients. Our multidisciplinary nature allows us to rapidly assemble diverse teams to tackle problems from multiple directions. We push the boundaries of science and technology to develop innovative solutions that advance the state of the art and improve human health and safety. Operating as a nonprofit since our 1947 inception, we work in the publics best interest and toward the betterment of humanity. And as a contract R&D organization, we are here when you need us. Learn more about how to WORK WITH US.

Source: Southwest Research Institute

See original here:
SwRI Awarded $1.9M Contract to Develop Treatment for COVID-19 in Collaboration with DOD - HPCwire

Scientists Have Engineered Human Cells With a Squid-Like Power of Invisibility – ScienceAlert

The opalescent inshore squid has a superpower. Not only can it change the colour of its skin - which many chephalopscan do -it can also turn parts of itself invisible. Now, scientists have used this ability on human cells.

Using special proteins found in the cells of these changeling squids, researchers managed to apply them to human kidney cells. Their findings could help us to better understand various cellular mechanisms in living tissue.

"Our project centres on designing and engineering cellular systems and tissues with controllable properties for transmitting, reflecting and absorbing light," explained biomolecular engineer Atrouli Chatterjee from the University of California (UCI).

A female opalescent inshore squid with her eggs. (Brent Durand/Moment/Getty Images)

Squids aren't the only animals to make use of see-through skin. While gliding lizards (Draco sumatranus) use their skin translucency to draw attention, opalescent inshore squids (Doryteuthis opalescens) use theirs to avoid unwanted attention.

Females of this squid species can turn a white stripe along their backs from opaque white to nearly transparent. They do this using specialised cells called leucophores, which have membrane-bound particles made of reflectin proteins.

Depending on how these proteins are arranged,they can change how light is transmitted or reflected around them. And it's not a random process: Squids can alter the arrangement of these highly refractive proteins within their cells, using an organic chemical called acetylcholine.

To try this trick in human tissue, the research team genetically engineered human kidney cells to produce reflectins, which clumped together as disordered particles in the cell's cytoplasm.

"We were amazed to find that the cells not only expressed reflectin but also packaged the protein in spheroidal nanostructures and distributed them throughout the cells' bodies," said UCI biomedical engineer Alon Gorodetsky.

Using quantitative phase microscopy, the researchers showed these proteins changed the way light was scattering through the engineered cells, compared to kidney cells without reflectin.

They then exposed the reflectin-expressing cells to different levels of sodium chloride and found they could adjust the levels of light being transmitted through them, as the salt made the reflectin particles swell in size, and change how they arranged themselves.

The more salt, the more light scattered, and the more opaque the cells became. The kidney cells now had tunable light-transmitting and light-reflecting capabilities - essentially an opacity dial of sorts.

Experimental setup. The cells became more opaque after exposure to salt (bottom). (Chatterjee et al, Nat. Commun, 2020)

The reflectin's reaction to salt "bore a superficial resemblance to the acetylcholine-triggered switching of the opacity and broadband reflectance for female D. opalescens squids' leucophore-containing layers", the researchers wrote in their paper.

The team says their success lays the groundwork for incorporating other squid tricks into mammalian cells, like changing colour patterns and iridescence.

It will also allow researchers to further explore the mechanisms behind these abilities, as so far, culturing cephalopod skin cells in a lab has proved very challenging.

Possible future applications could include the ability to image entire living tissues with improved clarity - allowing us to find things that weren't apparent before. The team pointed out how similar studies on jellyfish's green fluorescent proteins led to their now popular use in fluorescence microscopy.

"Our findings may afford a variety of exciting opportunities and possibilities within the fields of biology, materials science, and bioengineering," the team concluded.

This research was published in Nature Communications.

Read more:
Scientists Have Engineered Human Cells With a Squid-Like Power of Invisibility - ScienceAlert

Potential impact of coronavirus outbreak on Dehydrated Vegetables Market Makers, Suppliers And Forecast 2020-2026 – Cole of Duty

The report Global Dehydrated Vegetables Market intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Also identifies and analyses the emerging trends along with major drivers, challenges, opportunities and entry strategies for various companies in the Global Dehydrated Vegetables Industry.Global Dehydrated Vegetables Market Research report provides information regarding market size, share, trends, growth, cost structure, capacity, revenue and forecast 2024. This report also includes the overall and comprehensive study of the Dehydrated Vegetables market with all its aspects influencing the growth of the market. This report is exhaustive quantitative analyses of the Dehydrated Vegetables industry and provides data for making strategies to increase the market growth and effectiveness.

The Global Dehydrated Vegetables market research provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Dehydrated Vegetables Market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

Request Free Sample Pages Of This Premium Research Report: https://www.researchmoz.us/enquiry.php?type=S&repid=2685344

The authors of the report have segmented the global Dehydrated Vegetables market as per product, application, and region. Segments of the global Dehydrated Vegetables market are analyzed on the basis of market share, production, consumption, revenue, CAGR, market size, and more factors. The analysts have profiled leading players of the global Dehydrated Vegetables market, keeping in view their recent developments, market share, sales, revenue, areas covered, product portfolios, and other aspects.The Dehydrated Vegetables market report helps the readers grasp the changing trend in the industry supply chain, manufacturing techniques and expenses, and current scenario of the end uses in the global Dehydrated Vegetables market.

All the players running in the global Dehydrated Vegetables market are elaborated thoroughly in the Dehydrated Vegetables market report on the basis of proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines R&D developments, legal policies, and strategies defining the competitiveness of the Dehydrated Vegetables market players.

This report covers leading companies associated in Dehydrated Vegetables market:

Scope of Dehydrated Vegetables Market:The global Dehydrated Vegetables market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

This Market Report includesdrivers and restraints of the global Dehydrated Vegetables market and their impact on each region during the forecast period. The report also comprises the study of current issues with consumers and opportunities. It also includes value chain analysis.

On the basis Of the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, Dehydrated Vegetables market share and growth rate of Dehydrated Vegetables foreach application, including-

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, Dehydrated Vegetables market share and growth rate ofeach type, primarily split into-

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.researchmoz.us/enquiry.php?type=E&repid=2685344

Dehydrated Vegetables Market: Regional analysis includes:

Dehydrated Vegetables Market Report Structure at a Glance:

For More Information Kindly Contact: ResearchMozMr. Rohit Bhisey,90 State Street,Albany NY,United States 12207Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected]Follow us on LinkedIn @ http://bit.ly/1TBmnVGMedia Release: https://www.researchmoz.us/pressreleaseFollow me on : http://marketresearchlatestreports.blogspot.com/

Read more from the original source:
Potential impact of coronavirus outbreak on Dehydrated Vegetables Market Makers, Suppliers And Forecast 2020-2026 - Cole of Duty

Glutamic Acid Market Development, Market Trends, Key Driven Factors, Segmentation And Forecast To 2020-2026 – Cole of Duty

The market research report is a brilliant, complete, and much-needed resource for companies, stakeholders, and investors interested in the global Glutamic Acid market. It informs readers about key trends and opportunities in the global Glutamic Acid market along with critical market dynamics expected to impact the global market growth. It offers a range of market analysis studies, including production and consumption, sales, industry value chain, competitive landscape, regional growth, and price. On the whole, it comes out as an intelligent resource that companies can use to gain a competitive advantage in the global Glutamic Acid market.

Key companies operating in the global Glutamic Acid market include , EPPEN Bioengineering Stock, Kyowa Hakko Bio, Bachem, Iris Biotech, Ajinomoto, Evonik Industries, Global Bio-Chem Technology Group Company, Ningxia, Sichuan Tongsheng Amino Acid, Suzhou Yuanfang Chemical, Akzo Nobel

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1540970/global-glutamic-acid-market

Segmental Analysis

Both developed and emerging regions are deeply studied by the authors of the report. The regional analysis section of the report offers a comprehensive analysis of the global Glutamic Acid market on the basis of region. Each region is exhaustively researched about so that players can use the analysis to tap into unexplored markets and plan powerful strategies to gain a foothold in lucrative markets.

Global Glutamic Acid Market Segment By Type:

, Biosynthesis, Industrial Synthesis

Global Glutamic Acid Market Segment By Application:

, Pharmaceutical, Food Additives, Animal & Pet Food

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Glutamic Acid market.

Key companies operating in the global Glutamic Acid market include , EPPEN Bioengineering Stock, Kyowa Hakko Bio, Bachem, Iris Biotech, Ajinomoto, Evonik Industries, Global Bio-Chem Technology Group Company, Ningxia, Sichuan Tongsheng Amino Acid, Suzhou Yuanfang Chemical, Akzo Nobel

Key questions answered in the report:

For Discount, COVID-19 Impact, Customization in the Report: https://www.qyresearch.com/customize-form/form/1540970/global-glutamic-acid-market

TOC

Table of Contents 1 Glutamic Acid Market Overview1.1 Glutamic Acid Product Overview1.2 Glutamic Acid Market Segment by Type1.2.1 Biosynthesis1.2.2 Industrial Synthesis1.3 Global Glutamic Acid Market Size by Type (2015-2026)1.3.1 Global Glutamic Acid Market Size Overview by Type (2015-2026)1.3.2 Global Glutamic Acid Historic Market Size Review by Type (2015-2020)

1.3.2.1 Global Glutamic Acid Sales Market Share Breakdown by Type (2015-2026)

1.3.2.2 Global Glutamic Acid Revenue Market Share Breakdown by Type (2015-2026)

1.3.2.3 Global Glutamic Acid Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Glutamic Acid Market Size Forecast by Type (2021-2026)

1.3.3.1 Global Glutamic Acid Sales Market Share Breakdown by Application (2021-2026)

1.3.3.2 Global Glutamic Acid Revenue Market Share Breakdown by Application (2021-2026)

1.3.3.3 Global Glutamic Acid Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Glutamic Acid Sales Breakdown by Type (2015-2026)1.4.2 Europe Glutamic Acid Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Glutamic Acid Sales Breakdown by Type (2015-2026)1.4.4 Latin America Glutamic Acid Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Glutamic Acid Sales Breakdown by Type (2015-2026) 2 Global Glutamic Acid Market Competition by Company2.1 Global Top Players by Glutamic Acid Sales (2015-2020)2.2 Global Top Players by Glutamic Acid Revenue (2015-2020)2.3 Global Top Players Glutamic Acid Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Glutamic Acid Manufacturing Base Distribution, Sales Area, Product Type2.5 Glutamic Acid Market Competitive Situation and Trends2.5.1 Glutamic Acid Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Glutamic Acid Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glutamic Acid as of 2019)2.7 Date of Key Manufacturers Enter into Glutamic Acid Market2.8 Key Manufacturers Glutamic Acid Product Offered2.9 Mergers & Acquisitions, Expansion 3 Global Glutamic Acid Status and Outlook by Region (2015-2026)3.1 Global Glutamic Acid Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Glutamic Acid Market Size Market Share by Region (2015-2020)3.2.1 Global Glutamic Acid Sales Market Share by Region (2015-2020)3.2.2 Global Glutamic Acid Revenue Market Share by Region (2015-2020)3.2.3 Global Glutamic Acid Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Glutamic Acid Market Size Market Share by Region (2021-2026)3.3.1 Global Glutamic Acid Sales Market Share by Region (2021-2026)3.3.2 Global Glutamic Acid Revenue Market Share by Region (2021-2026)3.3.3 Global Glutamic Acid Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Glutamic Acid Market Size YoY Growth (2015-2026)3.4.1 North America Glutamic Acid Revenue YoY Growth (2015-2026)3.4.2 North America Glutamic Acid Sales YoY Growth (2015-2026)3.5 Asia-Pacific Glutamic Acid Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Glutamic Acid Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Glutamic Acid Sales YoY Growth (2015-2026)3.6 Europe Glutamic Acid Market Size YoY Growth (2015-2026)3.6.1 Europe Glutamic Acid Revenue YoY Growth (2015-2026)3.6.2 Europe Glutamic Acid Sales YoY Growth (2015-2026)3.7 Latin America Glutamic Acid Market Size YoY Growth (2015-2026)3.7.1 Latin America Glutamic Acid Revenue YoY Growth (2015-2026)3.7.2 Latin America Glutamic Acid Sales YoY Growth (2015-2026)3.8 Middle East and Africa Glutamic Acid Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Glutamic Acid Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Glutamic Acid Sales YoY Growth (2015-2026) 4 Global Glutamic Acid by Application4.1 Glutamic Acid Segment by Application4.1.1 Pharmaceutical4.1.2 Food Additives4.1.3 Animal & Pet Food4.2 Global Glutamic Acid Sales by Application: 2015 VS 2020 VS 20264.3 Global Glutamic Acid Historic Sales by Application (2015-2020)4.4 Global Glutamic Acid Forecasted Sales by Application (2021-2026)4.5 Key Regions Glutamic Acid Market Size by Application4.5.1 North America Glutamic Acid by Application4.5.2 Europe Glutamic Acid by Application4.5.3 Asia-Pacific Glutamic Acid by Application4.5.4 Latin America Glutamic Acid by Application4.5.5 Middle East and Africa Glutamic Acid by Application 5 North America Glutamic Acid Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Glutamic Acid Sales Market Share by Country (2015-2020)5.1.2 North America Glutamic Acid Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Glutamic Acid Sales Market Share by Country (2021-2026)5.2.2 North America Glutamic Acid Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Glutamic Acid Market Size YoY Growth (2015-2026)5.3.2 Canada Glutamic Acid Market Size YoY Growth (2015-2026) 6 Europe Glutamic Acid Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Glutamic Acid Sales Market Share by Country (2015-2020)6.1.2 Europe Glutamic Acid Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Glutamic Acid Sales Market Share by Country (2021-2026)6.2.2 Europe Glutamic Acid Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Glutamic Acid Market Size YoY Growth (2015-2026)6.3.2 France Glutamic Acid Market Size YoY Growth (2015-2026)6.3.3 U.K. Glutamic Acid Market Size YoY Growth (2015-2026)6.3.4 Italy Glutamic Acid Market Size YoY Growth (2015-2026)6.3.5 Russia Glutamic Acid Market Size YoY Growth (2015-2026) 7 Asia-Pacific Glutamic Acid Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Glutamic Acid Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Glutamic Acid Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Glutamic Acid Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Glutamic Acid Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Glutamic Acid Market Size YoY Growth (2015-2026)7.3.2 Japan Glutamic Acid Market Size YoY Growth (2015-2026)7.3.3 South Korea Glutamic Acid Market Size YoY Growth (2015-2026)7.3.4 India Glutamic Acid Market Size YoY Growth (2015-2026)7.3.5 Australia Glutamic Acid Market Size YoY Growth (2015-2026)7.3.6 Taiwan Glutamic Acid Market Size YoY Growth (2015-2026)7.3.7 Indonesia Glutamic Acid Market Size YoY Growth (2015-2026)7.3.8 Thailand Glutamic Acid Market Size YoY Growth (2015-2026)7.3.9 Malaysia Glutamic Acid Market Size YoY Growth (2015-2026)7.3.10 Philippines Glutamic Acid Market Size YoY Growth (2015-2026)7.3.11 Vietnam Glutamic Acid Market Size YoY Growth (2015-2026) 8 Latin America Glutamic Acid Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Glutamic Acid Sales Market Share by Country (2015-2020)8.1.2 Latin America Glutamic Acid Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Glutamic Acid Sales Market Share by Country (2021-2026)8.2.2 Latin America Glutamic Acid Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Glutamic Acid Market Size YoY Growth (2015-2026)8.3.2 Brazil Glutamic Acid Market Size YoY Growth (2015-2026)8.3.3 Argentina Glutamic Acid Market Size YoY Growth (2015-2026) 9 Middle East and Africa Glutamic Acid Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Glutamic Acid Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Glutamic Acid Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Glutamic Acid Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Glutamic Acid Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Glutamic Acid Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Glutamic Acid Market Size YoY Growth (2015-2026)9.3.3 U.A.E Glutamic Acid Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Glutamic Acid Business10.1 EPPEN Bioengineering Stock10.1.1 EPPEN Bioengineering Stock Corporation Information10.1.2 EPPEN Bioengineering Stock Description, Business Overview and Total Revenue10.1.3 EPPEN Bioengineering Stock Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.1.4 EPPEN Bioengineering Stock Glutamic Acid Products Offered10.1.5 EPPEN Bioengineering Stock Recent Development10.2 Kyowa Hakko Bio10.2.1 Kyowa Hakko Bio Corporation Information10.2.2 Kyowa Hakko Bio Description, Business Overview and Total Revenue10.2.3 Kyowa Hakko Bio Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.2.5 Kyowa Hakko Bio Recent Development10.3 Bachem10.3.1 Bachem Corporation Information10.3.2 Bachem Description, Business Overview and Total Revenue10.3.3 Bachem Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.3.4 Bachem Glutamic Acid Products Offered10.3.5 Bachem Recent Development10.4 Iris Biotech10.4.1 Iris Biotech Corporation Information10.4.2 Iris Biotech Description, Business Overview and Total Revenue10.4.3 Iris Biotech Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.4.4 Iris Biotech Glutamic Acid Products Offered10.4.5 Iris Biotech Recent Development10.5 Ajinomoto10.5.1 Ajinomoto Corporation Information10.5.2 Ajinomoto Description, Business Overview and Total Revenue10.5.3 Ajinomoto Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.5.4 Ajinomoto Glutamic Acid Products Offered10.5.5 Ajinomoto Recent Development10.6 Evonik Industries10.6.1 Evonik Industries Corporation Information10.6.2 Evonik Industries Description, Business Overview and Total Revenue10.6.3 Evonik Industries Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.6.4 Evonik Industries Glutamic Acid Products Offered10.6.5 Evonik Industries Recent Development10.7 Global Bio-Chem Technology Group Company10.7.1 Global Bio-Chem Technology Group Company Corporation Information10.7.2 Global Bio-Chem Technology Group Company Description, Business Overview and Total Revenue10.7.3 Global Bio-Chem Technology Group Company Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.7.4 Global Bio-Chem Technology Group Company Glutamic Acid Products Offered10.7.5 Global Bio-Chem Technology Group Company Recent Development10.8 Ningxia10.8.1 Ningxia Corporation Information10.8.2 Ningxia Description, Business Overview and Total Revenue10.8.3 Ningxia Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.8.4 Ningxia Glutamic Acid Products Offered10.8.5 Ningxia Recent Development10.9 Sichuan Tongsheng Amino Acid10.9.1 Sichuan Tongsheng Amino Acid Corporation Information10.9.2 Sichuan Tongsheng Amino Acid Description, Business Overview and Total Revenue10.9.3 Sichuan Tongsheng Amino Acid Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.9.4 Sichuan Tongsheng Amino Acid Glutamic Acid Products Offered10.9.5 Sichuan Tongsheng Amino Acid Recent Development10.10 Suzhou Yuanfang Chemical10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 Glutamic Acid Product Category, Application and Specification10.10.3 Suzhou Yuanfang Chemical Glutamic Acid Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 Suzhou Yuanfang Chemical Recent Development10.11 Akzo Nobel10.11.1 Akzo Nobel Corporation Information10.11.2 Akzo Nobel Description, Business Overview and Total Revenue10.11.3 Akzo Nobel Glutamic Acid Sales, Revenue and Gross Margin (2015-2020)10.11.4 Akzo Nobel Glutamic Acid Products Offered10.11.5 Akzo Nobel Recent Development 11 Glutamic Acid Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Glutamic Acid Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Glutamic Acid Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Market Opportunities and Drivers11.4.2 Market Challenges11.4.3 Market Risks11.4.4 Porters Five Forces Analysis 12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

See the article here:
Glutamic Acid Market Development, Market Trends, Key Driven Factors, Segmentation And Forecast To 2020-2026 - Cole of Duty

2020 Trending Ultrasonic Cell Disrupter Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,…

Ultrasonic Cell DisrupterMarket 2020: Inclusive Insight

Los Angeles, United States, May 2020:The report titled Global Ultrasonic Cell Disrupter Market is one of the most comprehensive and important additions to Alexareports archive of market research studies. It offers detailed research and analysis of key aspects of the global Ultrasonic Cell Disrupter market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Ultrasonic Cell Disrupter market. Market participants can use the analysis on market dynamics to plan effective growth strategies and prepare for future challenges beforehand. Each trend of the global Ultrasonic Cell Disrupter market is carefully analyzed and researched about by the market analysts.

Global Ultrasonic Cell Disrupter Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2025. According to the latest report added to the online repository of Alexareports the Ultrasonic Cell Disrupter market has witnessed an unprecedented growth till 2020. The extrapolated future growth is expected to continue at higher rates by 2025.

Get PDF Sample Copy of the Report to understand the structure of the complete report:(Including Full TOC, List of Tables & Figures, Chart) : https://www.alexareports.com/report-sample/850717

Ultrasonic Cell Disrupter Market competition by top manufacturers/ Key player Profiled: WIGGENS, Sonicator, Sonics & Materials, Diagenode, Hielscher, Branson Industrial Automation, Cole-Parmer, WHEATON, ATS, HANUO, Shanghai Shengyan Ultrusonic Equipment, Taikang, Nanjing PNA Instruments, Scientz

Moreover, with thisUltrasonic Cell Disrupter market report, all the participants and the retailers will be in conscious of the growth factors, shortcomings, threats, and the profitable opportunities that the market will offer in the near future. The report also features the revenue of the market;Ultrasonic Cell Disrupterindustry Trends, manufacture volume, and consumption in order to gain perceptions about the politics and tussle of gaining control of an enormous chunk of theUltrasonic Cell Disrupter market share.

Based on region, the globalUltrasonic Cell Disrupter market has been segmented into Americas (North America ((the U.S. and Canada),) and Latin Americas), Europe (Western Europe (Germany, France, Italy, Spain, UK and Rest of Europe) and Eastern Europe), Asia Pacific (Japan, India, China, Australia & South Korea, and Rest of Asia Pacific), and Middle East & Africa (Saudi Arabia, UAE, Kuwait, Qatar, South Africa, and Rest of Middle East & Africa).

Ultrasonic Cell Disrupter Market Segment by Type covers: Conventional Ultrasonic Cell Disrupter, Intelligent Ultrasonic Cell Disrupter

Ultrasonic Cell Disrupter Market Segment by Industry: Pharmaceuticals, Bioengineering

The Essential Content Covered in the GlobalUltrasonic Cell Disrupter Market Report :

* Top Key Company Profiles.* Main Business and Rival Information* SWOT Analysis and PESTEL Analysis* Production, Sales, Revenue, Price and Gross Margin* Market Share and Size

Key questions answered in the report:

What will the market growth rate of Ultrasonic Cell Disrupter market?What are the key factors driving the global Ultrasonic Cell Disrupter market size?Who are the key manufacturers in Ultrasonic Cell Disrupter market space?What are the market opportunities, market risk and market overview of the Ultrasonic Cell Disruptermarket?What are sales, revenue, and price analysis of top manufacturers of Ultrasonic Cell Disrupter market?Who are the distributors, traders, and dealers of Ultrasonic Cell Disrupter market?What are the Ultrasonic Cell Disrupter market opportunities and threats faced by the vendors in the global Ultrasonic Cell Disrupterindustries?What are sales, revenue, and price analysis by types and applications of Ultrasonic Cell Disruptermarket?What are sales, revenue, and price analysis by regions of Ultrasonic Cell Disrupter industries?

Get a discount on this report now at https://www.alexareports.com/check-discount/850717

Table of ContentsSection 1 Ultrasonic Cell Disrupter Product DefinitionSection 2 Global Ultrasonic Cell Disrupter Market Manufacturer Share and Market Overview2.1 Global Manufacturer Ultrasonic Cell Disrupter Shipments2.2 Global Manufacturer Ultrasonic Cell Disrupter Business Revenue2.3 Global Ultrasonic Cell Disrupter Market Overview2.4 COVID-19 Impact on Ultrasonic Cell Disrupter IndustrySection 3 Manufacturer Ultrasonic Cell Disrupter Business Introduction3.1 WIGGENS Ultrasonic Cell Disrupter Business Introduction3.1.1 WIGGENS Ultrasonic Cell Disrupter Shipments, Price, Revenue and Gross profit 2014-20193.1.2 WIGGENS Ultrasonic Cell Disrupter Business Distribution by Region3.1.3 WIGGENS Interview Record3.1.4 WIGGENS Ultrasonic Cell Disrupter Business Profile3.1.5 WIGGENS Ultrasonic Cell Disrupter Product Specification3.2 Sonicator Ultrasonic Cell Disrupter Business Introduction3.2.1 Sonicator Ultrasonic Cell Disrupter Shipments, Price, Revenue and Gross profit 2014-20193.2.2 Sonicator Ultrasonic Cell Disrupter Business Distribution by Region3.2.3 Interview Record3.2.4 Sonicator Ultrasonic Cell Disrupter Business Overview3.2.5 Sonicator Ultrasonic Cell Disrupter Product Specification3.3 Sonics & Materials Ultrasonic Cell Disrupter Business Introduction3.3.1 Sonics & Materials Ultrasonic Cell Disrupter Shipments, Price, Revenue and Gross profit 2014-20193.3.2 Sonics & Materials Ultrasonic Cell Disrupter Business Distribution by Region3.3.3 Interview Record3.3.4 Sonics & Materials Ultrasonic Cell Disrupter Business Overview3.3.5 Sonics & Materials Ultrasonic Cell Disrupter Product Specification3.4 Diagenode Ultrasonic Cell Disrupter Business Introduction3.5 Hielscher Ultrasonic Cell Disrupter Business Introduction3.6 Branson Industrial Automation Ultrasonic Cell Disrupter Business IntroductionSection 4 Global Ultrasonic Cell Disrupter Market Segmentation (Region Level)4.1 North America Country4.1.1 United States Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.1.2 Canada Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.2 South America Country4.2.1 South America Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.3 Asia Country4.3.1 China Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.3.2 Japan Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.3.3 India Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.3.4 Korea Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.4 Europe Country4.4.1 Germany Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.4.2 UK Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.4.3 France Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.4.4 Italy Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.4.5 Europe Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.5 Other Country and Region4.5.1 Middle East Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.5.2 Africa Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.5.3 GCC Ultrasonic Cell Disrupter Market Size and Price Analysis 2014-20194.6 Global Ultrasonic Cell Disrupter Market Segmentation (Region Level) Analysis 2014-20194.7 Global Ultrasonic Cell Disrupter Market Segmentation (Region Level) AnalysisSection 5 Global Ultrasonic Cell Disrupter Market Segmentation (Product Type Level)5.1 Global Ultrasonic Cell Disrupter Market Segmentation (Product Type Level) Market Size 2014-20195.2 Different Ultrasonic Cell Disrupter Product Type Price 2014-20195.3 Global Ultrasonic Cell Disrupter Market Segmentation (Product Type Level) AnalysisSection 6 Global Ultrasonic Cell Disrupter Market Segmentation (Industry Level)6.1 Global Ultrasonic Cell Disrupter Market Segmentation (Industry Level) Market Size 2014-20196.2 Different Industry Price 2014-20196.3 Global Ultrasonic Cell Disrupter Market Segmentation (Industry Level) AnalysisSection 7 Global Ultrasonic Cell Disrupter Market Segmentation (Channel Level)7.1 Global Ultrasonic Cell Disrupter Market Segmentation (Channel Level) Sales Volume and Share 2014-20197.2 Global Ultrasonic Cell Disrupter Market Segmentation (Channel Level) AnalysisSection 8 Ultrasonic Cell Disrupter Market Forecast 2019-20248.1 Ultrasonic Cell Disrupter Segmentation Market Forecast (Region Level)8.2 Ultrasonic Cell Disrupter Segmentation Market Forecast (Product Type Level)8.3 Ultrasonic Cell Disrupter Segmentation Market Forecast (Industry Level)8.4 Ultrasonic Cell Disrupter Segmentation Market Forecast (Channel Level)Section 9 Ultrasonic Cell Disrupter Segmentation Product Type9.1 Conventional Ultrasonic Cell Disrupter Product Introduction9.2 Intelligent Ultrasonic Cell Disrupter Product IntroductionSection 10 Ultrasonic Cell Disrupter Segmentation Industry10.1 Pharmaceuticals Clients10.2 Bioengineering ClientsSection 11 Ultrasonic Cell Disrupter Cost of Production Analysis11.1 Raw Material Cost Analysis11.2 Technology Cost Analysis11.3 Labor Cost Analysis11.4 Cost OverviewSection 12 Conclusion

Do Inquiry About The Report Here: https://www.alexareports.com/send-an-enquiry/850717

About Us:Alexa Reports is a globally celebrated premium market research service provider, with a strong legacy of empowering business with years of experience. We help our clients by implementing decision support system through progressive statistical surveying, in-depth market analysis, and reliable forecast data.

Contact Us:Alexa ReportsPh no: +1-408-844-4624Email: [emailprotected]Site: https://www.alexareports.com

Read the original:
2020 Trending Ultrasonic Cell Disrupter Market Estimated To Experience A Hike in Growth | Global Industry Size, Growth, Segments, Revenue,...

How US expertise may have inadvertently contributed to COVID-19 – WION

There are only three possible origins for the COVID-19 pandemic:

(1) It is a naturally-occurring disease, where coronaviruses circulating in a bat population mutated and acquired the ability to infect humans, which was then transmitted to people either visiting or working in the Wuhan Seafood Market;

(2) A yet unknown and undescribed coronavirus of natural origin, now named COVID-19, was one of the many bat coronaviruses isolated from bat populations by Chinese scientists and leaked from a Wuhan laboratory;

(3) COVID-19 was man-made and leaked from a Wuhan laboratory.

The Chinese government, the media and some scientists are desperately trying to convince the public that COVID-19 is a naturally-occurring disease because certain vested interests may be affected, including the potentially devastating political and economic consequences for China, global corporate and private investment in China and an effect on ongoing scientific collaboration and research funding.

Viruses, which can undergo frequent mutation, do jump from animals to humans after acquiring an ability to infect humans. That may prove to be the case for COVID-19.

Arguing against that conclusion are the facts that the initial patients hospitalised between December 1-10, 2019 had not visited the Wuhan Seafood Market, there were no bats in that market and there is no clear evolutionary pathway yet identified that explains the unique features of COVID-19.

The claim that COVID-19 is naturally-occurring is based nearly entirely on a single, but widely-cited Nature Medicine article entitled The Proximal Origin of SAR-CoV-2, which compares the structure of COVID-19 to what the authors consider its closest relatives found in animal populations, specifically, the bat coronavirus RaTG13 and a coronavirus from the scaly anteater, called pangolins.

There are, however, inconsistencies that do not fully support that claim.

Although COVID-19 bears a striking structural similarity to the bat coronavirus RaTG13, the critical receptor binding domain, which initiates attachment to human cells, is closer to that of pangolins.

In addition, there is no explanation for the origin of the furin polybasic cleavage site as represented by the proline-arginine-arginine-alanine (PRRA) amino acid insertion, which does not exist in any of the bat or pangolin close relatives yet identified, a structure that is known to enhance pathogenicity and transmissibility in coronaviruses.

Alternatively, the inconsistencies of the naturally-occurring argument could be resolved if one assumes that COVID-19 was bioengineered.

There are two USpatents related to that type of bioengineering, Methods and Compositions for Chimeric Coronavirus Spike Proteins and Insertion of Furin Protease Cleavage Sites in Membrane Proteins and Uses Thereof, patent numbers US9884895B2 and US7223390, respectively.

Viruses rely on the biochemical mechanisms of the host cell they invade to bind and fuse with the host cell membrane and replicate inside the cell.

The binding and membrane-fusing capability of COVID-19 resides in a structure called the spike protein, specifically sections of the S protein, which contain the receptor-binding domain and the furin polybasic cleavage site.

The bioengineering capabilities to splice the receptor-binding domain from one virus to another and to insert a furin polybasic cleavage site are both well-established laboratory techniques for which I provide the following specific examples.

In 2015, Ralph Baric from the University of North Carolina, co-patent holder of US9884895B2, and Zheng-Li Shi, the bat woman from the Wuhan Institute of Virology jointly published a scientific article describing the combination of the receptor-binding spike protein from a newly isolated coronavirus (SHC014) and the backbone from SARS-CoV, the coronavirus responsible for the 2002-2003 pandemic.

The above experiment produced a novel virus, chimera SHC014-MA15, which showed robust viral replication both in vitro [cell cultures] and in vivo [animals], using models adapted to test human infectivity.

In 2013, Chinese scientists demonstrated the capability to insert a furin polybasic cleavage site, similar to that of COVID-19, into a protein, an article which cited US patent Insertion of Furin Protease Cleavage Sites in Membrane Proteins and Uses Thereof.

One of the authors of that 2013 article, Chinese scientist Shibo Jiang, has a joint appointment at the Lindsley F. Kimball Research Institute in New York and Fudan University in Shanghai and is a long-time collaborator of Zheng-Li Shi and Ralph Baric in coronavirus research.

All of the above is not meant to assign complicity or culpability in any way, but to demonstrate that the bioengineering capability to manufacture COVID-19 clearly exists and should be investigated as its possible origin.

(Disclaimer: The opinions expressed above are the personal views of the author and do not reflect the views of ZMCL)

See original here:
How US expertise may have inadvertently contributed to COVID-19 - WION

COVID-19: Potential impact on Vertical Garden Construction Market 2020 Industry Demand, Share, Trend and Research Methodology by Forecast to 2027 -…

The report on the Vertical Garden Construction market provides a birds eye view of the current proceeding within the Vertical Garden Construction market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Vertical Garden Construction market and offers a clear assessment of the projected market fluctuations during the forecast period. The different factors that are likely to impact the overall dynamics of the Vertical Garden Construction market over the forecast period (2019-2029) including the current trends, growth opportunities, restraining factors, and more are discussed in detail in the market study.

The Vertical Garden Construction market study is a well-researched report encompassing a detailed analysis of this industry with respect to certain parameters such as the product capacity as well as the overall market remuneration. The report enumerates details about production and consumption patterns in the business as well, in addition to the current scenario of the Vertical Garden Construction market and the trends that will prevail in this industry.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2672893&source=atm

What pointers are covered in the Vertical Garden Construction market research study?

The Vertical Garden Construction market report Elucidated with regards to the regional landscape of the industry:

The geographical reach of the Vertical Garden Construction market has been meticulously segmented into United States, China, Europe, Japan, Southeast Asia & India, according to the report.

The research enumerates the consumption market share of every region in minute detail, in conjunction with the production market share and revenue.

Also, the report is inclusive of the growth rate that each region is projected to register over the estimated period.

The Vertical Garden Construction market report Elucidated with regards to the competitive landscape of the industry:

The competitive expanse of this business has been flawlessly categorized into companies such as

Key market playersMajor competitors identified in this market include A+ Lawn & Landscape, American Hydrotech, ANS Group Global, Biotecture, Four Leaf Landscape, GreenWalls Bioengineering, Livewall, Sempergreen, The Greenwall Company, ZTC International Landscape Solutions, etc.

Based on the Region:Asia-Pacific (China, Japan, South Korea, India and ASEAN)North America (US and Canada)Europe (Germany, France, UK and Italy)Rest of World (Latin America, Middle East & Africa)

Based on the Type:Indoor Vertical Garden WallOutdoor Vertical Garden Wall

Based on the Application:ResidentialCommercial

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2672893&source=atm

Exclusive details pertaining to the contribution that every firm has made to the industry have been outlined in the study. Not to mention, a brief gist of the company description has been provided as well.

Substantial information subject to the production patterns of each firm and the area that is catered to, has been elucidated.

The valuation that each company holds, in tandem with the description as well as substantial specifications of the manufactured products have been enumerated in the study as well.

The Vertical Garden Construction market research study conscientiously mentions a separate section that enumerates details with regards to major parameters like the price fads of key raw material and industrial chain analysis, not to mention, details about the suppliers of the raw material. That said, it is pivotal to mention that the Vertical Garden Construction market report also expounds an analysis of the industry distribution chain, further advancing on aspects such as important distributors and the customer pool.

The Vertical Garden Construction market report enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2672893&licType=S&source=atm

Some of the Major Highlights of TOC covers:

See the article here:
COVID-19: Potential impact on Vertical Garden Construction Market 2020 Industry Demand, Share, Trend and Research Methodology by Forecast to 2027 -...

IIT Guwahati finds pathways that may extend onset of the Alzheimers disease – Times of India

GUWAHATI: Researchers at Indian Institute of Technology Guwahati are working on out-of-the-box ideas that can help prevent or reduce short-term memory losses associated with Alzheimers disease.

Our research has provided a different path that may extend the onset of the Alzheimers disease. However, it would take testing in animal models and clinical trials before bringing in such new therapeutic approaches into human treatment said one of the project coordinators, Professor Vibin Ramakrishnan of Department of Biosciences and Bioengineering at the institute.

The IIT Guwahati team reports interesting methods such as application of low-voltage electric field, and the use of trojan peptides to arrest aggregation of neurotoxic molecules in the brain. The scientists are assisted by research scholars Dr. Gaurav Pandey and Jahnu Saikia in their work, and the results of their studies have been published in reputed journals such as ACS Chemical Neuroscience, RSC Advances of Royal Society of Chemistry, BBA and Neuropeptides, a statement said.

Approximately hundred potential drugs for treatment of Alzheimers disease have failed between 1998 and 2011, which shows the gravity of the problem, says Professor Ramakrishnan, who participates in worldwide efforts at finding cures for the disease.

A defining hallmark of Alzheimers is the accumulation of Amyloid beta peptides in the brain. Dr. Ramakrishnan and Dr. Nemade are seeking methods to reduce the accumulation of these peptides, in order to arrest the progression of Alzeimers.

Original post:
IIT Guwahati finds pathways that may extend onset of the Alzheimers disease - Times of India

NIH mobilizes national innovation initiative for COVID-19 diagnostics – National Institutes of Health

News Release

Wednesday, April 29, 2020

Initiative aims to speed delivery of accurate, easy-to-use, scalable tests to all Americans.

The National Institutes of Health today announced a new initiative aimed at speeding innovation, development and commercialization of COVID-19 testing technologies, a pivotal component needed to return to normal during this unprecedented global pandemic. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of Diagnostics (RADx) initiative will infuse funding into early innovative technologies to speed development of rapid and widely accessible COVID-19 testing. At the same time, NIH will seek opportunities to move more advanced diagnostic technologies swiftly through the development pipeline toward commercialization and broad availability. NIH will work closely with the U.S. Food and Drug Administration, the Centers for Disease Control and Prevention and the Biomedical Advanced Research and Development Authority (BARDA) to advance these goals.

The stimulus investment supercharges NIHs strong research efforts already underway focused on prevention and treatment of COVID-19, including the recently announced planned Accelerating COVID-19 Therapeutic Interventions and Vaccines public-private partnership to coordinate the international research response to the pandemic.

We need all innovators, from the basement to the boardroom, to come together to advance diagnostic technologies, no matter where they are in development, said NIH Director Francis S. Collins, M.D., Ph.D. Now is the time for that unmatched American ingenuity to bring the best and most innovative technologies forward to make testing for COVID-19 widely available.

As part of this initiative, NIH is urging all scientists and inventors with a rapid testing technology to compete in a national COVID-19 testing challenge for a share of up to $500 million over all phases of development. The technologies will be put through a highly competitive, rapid three-phase selection process to identify the best candidates for at-home or point-of-care tests for COVID-19. Finalists will be matched with technical, business and manufacturing experts to increase the odds of success. If certain selected technologies are already relatively far along in development, they can be put on a separate track and be immediately advanced to the appropriate step in the commercialization process.The goal is to make millions of accurate and easy-to-use tests per week available to all Americans by the end of summer 2020, and even more in time for the flu season.

Americans are innovators and makers, said Bruce J. Tromberg, Ph.D., director of NIHs National Institute of Biomedical Imaging and Bioengineering (NIBIB). We need American tech experts, innovators and entrepreneurs to step up to one of the toughest challenges weve faced as a country, to help get us safely back to public spaces.

While diagnostic testing has long been a mainstay of public health, newer technologies offer patient- and user-friendly designs, mobile-device integration, reduced cost and increased accessibility both at home and at the point of care. RADx will expand the Point-of-Care Technologies Research Network (POCTRN) established several years ago by NIBIB. The network will use a flexible, rapid process to infuse funding and enhance technology designs at key stages of development, with expertise from technology innovators, entrepreneurs and business leaders across the country. POCTRN supports hundreds of investigators from multiple universities and businesses through five technology hubs:

Led by the Coordinating Center at CIMIT, the network has assembled expert review boards covering scientific, clinical, regulatory and business domains that will rapidly evaluate technology proposals. In order to roll out new products starting at the end of summer/fall 2020, a rapid, parallel process will allow quick throughput of projects. Projects will be assessed at each milestone and must demonstrate significant progress to receive continued support.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

The rest is here:
NIH mobilizes national innovation initiative for COVID-19 diagnostics - National Institutes of Health

UC Engineers Aid Development Of Thermal Imaging Cameras To Spot COVID-19 Symptoms – Scoop.co.nz

Friday, 1 May 2020, 2:42 pmPress Release: University of Canterbury

The University of Canterburys Mechanical Engineeringexperts are among the Kiwi innovators battling againstCOVID-19.

While commercial devices for crowd feverdetection exist, the global pandemic has made them hard tocome by. The CacophonyProject and2040 developed low-cost smart thermal camera systems fortracking the predators that threaten New Zealands nativebirds, and have been pivoting the technology to meet thisurgent need.

Working with the University ofCanterbury, Callaghan Innovation, and the AucklandBioengineering Institute with testing, calibration andwriting for the instruction manual, they have repurposedtheir technology for crowd fever scanning at a safedistance. The system can measure forehead temperature to+/-0.5C without a human operator.

UC mechanicalengineers JulianPhillips, Lecturer TimGiffney and Professor MarkJermy have developed a temperature reference to give aconstant check calibration of these devices. The devices areunder trial and hoped to be implemented shortly to curb thespread of the virus.

If thermal imaging cameras aredeployed for temperature screening, this stable temperaturereference can help with accuracy. We hope this stablein-frame temperature reference could be useful as a simple,rapidly deliverable approach, UC Engineering Lecturer TimGiffney says.

By putting a stable temperaturesource in view of the camera, the system can continuouslycheck its reading, and make adjustments, UC Engineeringtechnician Julian Phillips adds.

The main challengein developing the reference was coming up with a design thatcould be rapidly built with minimal resources, and fromlocal supplies as international freight is at an almostcomplete standstill.

Fortunately I have quite awell-equipped workshop at home, needing only a few items tobe obtained from UC, Phillips says. In January Itravelled to Tonga to support a team of ourUC biomedical engineering students working on donatedmedical equipment. The experience of working underconstrained resources was good preparation for working underlockdown a similar level of flexibility and tenacity isrequired to get the job done.

About 30 soldiersfrom Burnham, as well as New Zealand Police officers, wereused to test and calibrate the cameras. To help control thespread of COVID-19 it is envisaged the cameras will be usedat airports, hospitals, supermarkets and otherworkplaces.

You can read more about the projecthere:

Coronavirus:Thermal imaging cameras to spot symptoms could be part ofnew normal

Kiwiinventors set their focus on Covid-19

Objects at close to human bodytemperature only emit a very small amount of radiated heat,which is difficult to detect in the camera sensor. Thismeans it is not easy to make an accurate thermal camera thatis insensitive to external conditions.

Comparingthe temperature of a surface to our reference at knowntemperature is less difficult. This could allow a widervariety of thermal imaging cameras to be used, which wouldbe useful in case of shortage.

The internalcorrection routines of some cameras can also causeinconsistent readings, which our method could helpcontinuously calibrateout.

Scoop Media

Visit link:
UC Engineers Aid Development Of Thermal Imaging Cameras To Spot COVID-19 Symptoms - Scoop.co.nz

Bioengineers Are Using Levitation on Dead Cells to Preserve the Living – Futurism

In the delicate work of bioengineering, dead cells get everywhere and become a major nuisance.

Now, Stanford scientists have figured out how to separate the dead cells from the living, using magnetic levitation, gently pulling them away from the still-useful survivors without ripping everything apart, according to New Scientist. Magnetic levitation itself isnt new, but learning that it can suck up dead cells is, and the scientists are eager to show how it can improve everything from cancer research to 3D-printed scaffolds.

Take cancer research, for example. In research shared online last month, the scientists suggest that an experimental drug could be dropped onto a clump of cells. As cancerous cells die, assuming they do, the scientists could levitate them away from the rest of the cells as a way to track and quantify their progress.

Without levitation, one of the main ways to separate living from dead cells is to spin them in a centrifuge until they form groups based on density. That process can be extremely destructive at the cellular scale, so the team argues that separating cells based on magnetic signatures is a far gentler (and therefore, more useful) approach.

Then theres 3D printing: being able to lift dead cells out of whatever organ or tissue youre trying to synthesize without scraping the good stuff along with it would make life much easier for scientists handling the extremely delicate work.

For now, the actual use-cases are speculative, though. Scientists have only gotten so far as learning that they can levitate dead cells without perturbing the survivors, but you cant fault them for letting their imaginations run a little wild with the possibilities.

Link:
Bioengineers Are Using Levitation on Dead Cells to Preserve the Living - Futurism

The nisin market is projected to grow at a CAGR of4.5% – GlobeNewswire

New York, June 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Nisin Market by Application and Region - Global Trends and Forecast to 2025" - https://www.reportlinker.com/p03793805/?utm_source=GNW Key factors, such as the increase in demand for clean label ingredient snacks and organic preservatives across regions, are projected to drive the growth of the nisin market during the forecast period. By application, the dairy product segment accounted for the largest share in 2019.

The dairy products segment is projected to dominate the application segment in the nisin market.For dairy products, such as cheese, nisin is the most preferred and effective preservative due to the heat treatment steps of pasteurization, which does not eliminate all the spores.

In addition, milk is sensitive to thermal treatment. Therefore, manufacturers prefer investing in nisin to preserve dairy products.North America accounted for the largest share in the global nisin market due to the higher acceptability and growing awareness toward clean label products.

The global nisin market is segmented region-wise, with a detailed analysis of each region.These regions include North America, Europe, Asia Pacific, and RoW.

The nisin market in the North American region is projected to be driven by the increase in consumer awareness toward organic and clean label ingredients.North America is a key manufacturer of the food & beverage industry.

Moreover, North America is one of the leading consumers of dairy products, processed food, and canned food products. Nisin is one of the non-toxic preservative options, which is gaining popularity among manufacturers.

Break-up of Primaries By Value Chain: Supply Side-43% and Demand Side-57% By Designation: D-level - 38%C-level -32%, and Others*-30% By Region: Europe - 36%, North America- 30%, Asia Pacific - 20%, and RoW**- 14%*Others include sales managers, marketing managers, and product managers.**RoW includes Brazil, Argentina, South Africa, and Others in RoW.

Leading players profiled in this report include the following: DSM (Netherlands) Galactic (Belgium) DuPont (US) Siveele B.V. (Netherlands) Zhejiang Silver-Elephant Bioengineering (China) Shandong Freda Biotechnology (China) Chihon Biotechnology (China) Mayasan Biotech (Turkey) Handary S.A. (Belgium) Cayman Chemicals (US)

Research CoverageThis report segments the nisin market, on the basis of application and region. In terms of insights, this research report focuses on various levels of analysescompetitive landscape, end-use analysis, and company profileswhich together comprise and discuss the basic views on the emerging & high-growth segments in the nisin market, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges.

Reasons to buy this report To get a comprehensive overview of the nisin market To gain wide-ranging information about the top players in this industry, their product portfolio details, and the key strategies adopted by them To gain insights about the major countries/regions, in which the nisin market is flourishingRead the full report: https://www.reportlinker.com/p03793805/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Here is the original post:
The nisin market is projected to grow at a CAGR of4.5% - GlobeNewswire